Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Eargo, Inc.
  6. News
  7. Summary
    EAR   US2700871096

EARGO, INC.

(EAR)
  Report
Delayed Nasdaq  -  04:00 2022-09-29 pm EDT
1.110 USD   -2.63%
08:02aEargo to Hold Investor Update Conference Call on October 4, 2022
GL
08:01aEargo to Hold Investor Update Conference Call on October 4, 2022
GL
09/20Eargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitation Web Site
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Eargo Rises on FDA Hearing Aid Announcement

08/16/2022 | 02:59pm EDT

By Josh Beckerman


Eargo Inc. shares rose 27% to $1.45 after the U.S. Food and Drug Administration said it would allow some hearing aids to be sold over-the-counter.

The FDA said the move will "improve access to hearing aids which may in turn lower costs for millions of Americans." It enables customers "with perceived mild to moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription or a fitting adjustment by an audiologist."


Write to Josh Beckerman at josh.beckerman@wsj.com


(END) Dow Jones Newswires

08-16-22 1458ET

All news about EARGO, INC.
08:02aEargo to Hold Investor Update Conference Call on October 4, 2022
GL
08:01aEargo to Hold Investor Update Conference Call on October 4, 2022
GL
09/20Eargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitatio..
GL
09/19Eargo, Inc.(NasdaqGS:EAR) dropped from S&P Global BMI Index
CI
08/18Top Premarket Decliners
MT
08/18Eargo 'Supports' FDA Approval for Sale of Over-The-Counter Hearing Aids
MT
08/17Eargo Supports Over-the-Counter Hearing Aid Final Ruling
GL
08/17Eargo Supports Over-the-Counter Hearing Aid Final Ruling
GL
08/17Top Midday Gainers
MT
08/17Eargo Shares Extend Gains into Pre-Market Wednesday After FDA Approves Sale of Over-The..
MT
More news
Analyst Recommendations on EARGO, INC.
More recommendations
Financials (USD)
Sales 2022 30,5 M - -
Net income 2022 - - -
Net Debt 2022 4,16 M - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 43,7 M 43,7 M -
EV / Sales 2022 1,57x
EV / Sales 2023 3,40x
Nbr of Employees 215
Free-Float 86,4%
Chart EARGO, INC.
Duration : Period :
Eargo, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EARGO, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 1,11 $
Average target price 2,00 $
Spread / Average Target 80,2%
EPS Revisions
Managers and Directors
Christian Gormsen President, Chief Executive Officer & Director
Adam Laponis Chief Financial Officer
Joshua Makower Non-Executive Chairman
Daniel Shen Chief Clinical & Science Officer
Fernando Cruz Vice President-Software & Engineering
Sector and Competitors
1st jan.Capi. (M$)
EARGO, INC.-78.24%44
THERMO FISHER SCIENTIFIC-22.58%202 402
DANAHER CORPORATION-20.32%190 700
INTUITIVE SURGICAL, INC.-47.38%67 515
BOSTON SCIENTIFIC CORPORATION-7.89%56 320
EDWARDS LIFESCIENCES CORPORATION-35.29%51 970